Drug profile · INN
pindolol
PINDOLOL
pindolol (PINDOLOL) is a beta-2 adrenergic receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — pindolol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pindolol (PINDOLOL) is a beta-2 adrenergic receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor partial agonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pindolol?
pindolol (PINDOLOL) is a beta-2 adrenergic receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pindolol?
PINDOLOL is a marketed brand name for pindolol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pindolol?
pindolol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.